Identifying risk factors for worsening chronic obstructive pulmonary disease
Official title: It is Crucial to Identify Predicting Risk Factors for Exacerbation of Chronic Obstructive Pulmonary Disease in Order to Provide Adequate Intensive Therapy and Closer Follow-up
Run by Xinhua Hospital, Shanghai Jiao Tong University School of Medicine · NCT03450603 · Data updated 2026-11-12
This study is trying to find out what factors make COPD symptoms worse in people aged 40 and older, so we can help them manage their condition better.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 40 Years and up |
| Sex | All |
| Enrollment | 200 (estimated) |
| Sponsor | Xinhua Hospital, Shanghai Jiao Tong University School of Medicine Academic / other |
| Locations | 1 site (Shanghai) |
| Status | Recruiting |
| Started | December 10, 2017 |
| Main results expected | December 30, 2027 |
| Study ends | December 30, 2027 |
| Registry record updated | March 11, 2026 |
| Trial ID | NCT03450603 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are individuals aged 40 and older with a clinical diagnosis of chronic obstructive pulmonary disease.
✕Probably not a fit
Patients with conditions such as asthma, lung cancer, or interstitial lung disease may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to identify risk factors that contribute to exacerbations in patients with chronic obstructive pulmonary disease (COPD). By analyzing the health outcomes of COPD patients, the study seeks to understand how different factors influence the severity and recovery from exacerbations. The goal is to distinguish patients who may require more intensive management to prevent adverse outcomes and improve their quality of life. The study will involve patients aged 40 and older who have a clinical diagnosis of COPD.
Why it matters
Potential benefit: If successful, this study could lead to better management strategies for COPD patients, reducing the frequency and severity of exacerbations.
How similar studies have gone: Other studies have shown success in identifying risk factors for COPD exacerbations, making this approach a continuation of established research.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Clinical diagnosis of Chronic obstructive pulmonary disease * aged \>= 40 years Exclusion Criteria: * spirometry can not be completed because of various reasons * asthma * pulmonary embolism * lung cancer * sequelae of tuberculosis * extensive bronchiectasis * interstitial lung disease * left cardiac insufficiency
Where it's running
-
Department of Respiratory Medicine, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
Shanghai, China Recruiting
Study contacts
- Study coordinator: Yue Zhang
- Email: zhangyue01@xinhuamed.com.cn
- Phone: +86-21-25077373
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Flutter therapy added to chest physiotherapy after CABG in COPD patients
This study tests whether adding Flutter therapy to standard chest physiotherapy helps post-CABG patients with mild-to-moderate COPD improve breathing more than chest physiotherapy alone.
-
TPB-based cadence exercise and breathing training for COPD patients
A TPB-based program tests whether breathing training, cadence-guided walking, or both can improve lung function, exercise capacity, and quality of life in adults with COPD.
-
See how dynamic chest X-rays relate to COPD patterns and progression risk
This study looks at existing dynamic chest radiography data to see if new imaging measurements can identify COPD patterns, gauge severity, and predict who may experience faster progression.
-
Personalized mobile app warnings to reduce COPD flares
A personalized mobile app tests whether providing temperature-related risk warnings and protective tips, in addition to usual COPD care, can lower COPD flare-ups over 12 months.
-
CLEAR model to predict when people with severe COPD can be taken off ventilatory support
This project will see if the CLEAR model can predict which adults with severe COPD on invasive or non‑invasive ventilation can be safely taken off ventilatory support.
-
Long-term safety of Tozorakimab in COPD patients with prior exacerbations
This study tests two long-term dosing regimens of tozorakimab in people with COPD who have a history of flare-ups and who completed earlier studies.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.